A retrospective evaluation of the role of T cells in the development of malaria vaccine

Experimental Parasitology

Volumn 126, Issue 3, 2010, Pages 421-425

  Tsuji, Moriya ^a  

^a AARON DIAMOND AIDS RESEARCH CENTER   (United States)

Author keywords

CD4+ T cells; CD8+ T cells; Hepatic stages; Immunity; Malaria; Vaccine

Indexed keywords

GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MALARIA VACCINE; T LYMPHOCYTE RECEPTOR;

ADOPTIVE TRANSFER; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG EFFICACY; ENDEMIC DISEASE; HUMAN; HUMORAL IMMUNITY; MALARIA; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE; ANIMAL; CELLULAR IMMUNITY; IMMUNOLOGY; LIVER; MOUSE; PARASITOLOGY; RETROSPECTIVE STUDY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; LIVER; MALARIA; MALARIA VACCINES; MICE; RETROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 77956239656     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2009.11.009     Document Type: Article

References (54)

1. Aidoo M., Lalvani A., Gilbert S.C., Hu J.T., Daubersies P., Hurt N., Whittle H.C., Druihle P., Hill A.V. Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect. Immun. 2000, 68:227-232.
2. Bonelo A., Valmori D., Triponez F., Tiercy J.M., Mentha G., Oberholzer J., Champagne P., Romero J.F., Esposito F., Nebie I., Barbey C., Romero P., Herrera S., Corradin G., Lopez J.A. Generation and characterization of malaria-specific human CD8(+) lymphocyte clones: effect of natural polymorphism on T cell recognition and endogenous cognate antigen presentation by liver cells. Eur. J. Immunol. 2000, 30:3079-3088.
3. Bongfen S.E., Torgler R., Romero J.F., Renia L., Corradin G. Plasmodium berghei-infected primary hepatocytes process and present the circumsporozoite protein to specific CD8+ T cells in vitro. J. Immunol. 2007, 178:7054-7063.
4. Calvo-Calle J.M., Oliveira G.A., Nardin E.H. Human CD4+ T cells induced by synthetic peptide malaria vaccine are comparable to cells elicited by attenuated Plasmodium falciparum sporozoites. J. Immunol. 2005, 175:7575-7585.
5. Carvalho L.H., Sano G., Hafalla J.C., Morrot A., Curotto de Lafaille M.A., Zavala F. IL-4-secreting CD4+ T cells are crucial to the development of CD8+ T-cell responses against malaria liver stages. Nat. Med. 2002, 8:166-170.
6. Chakravarty S., Baldeviano G.C., Overstreet M.G., Zavala F. Effector CD8+ T lymphocytes against liver stages of Plasmodium yoelii do not require gamma interferon for antiparasite activity. Infect. Immun. 2008, 76:3628-3631.
7. Chakravarty S., Cockburn I.A., Kuk S., Overstreet M.G., Sacci J.B., Zavala F. CD8+ T lymphocytes protective against malaria liver stages are primed in skin-draining lymph nodes. Nat. Med. 2007, 13:1035-1041.
8. Doolan D.L., Hoffman S.L. The complexity of protective immunity against liver-stage malaria. J. Immunol. 2000, 165:1453-1462.
9. Doolan D.L., Sedegah M., Hedstrom R.C., Hobart P., Charoenvit Y., Hoffman S.L. Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity. J. Exp. Med. 1996, 183:1739-1746.
10. Doolan D.L., Southwood S., Freilich D.A., Sidney J., Graber N.L., Shatney L., Bebris L., Florens L., Dobano C., Witney A.A., Appella E., Hoffman S.L., Yates J.R., Carucci D.J., Sette A. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 2003, 100:9952-9957.
11. Ferreira A., Schofield L., Enea V., Schellekens H., van der Meide P., Collins W.E., Nussenzweig R.S., Nussenzweig V. Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science 1986, 232:881-884.
12. Hafalla J.C., Sano G., Carvalho L.H., Morrot A., Zavala F. Short-term antigen presentation and single clonal burst limit the magnitude of the CD8(+) T cell responses to malaria liver stages. Proc. Natl. Acad. Sci. USA 2002, 99:11819-11824.
13. Hill A.V., Elvin J., Willis A.C., Aidoo M., Allsopp C.E., Gotch F.M., Gao X.M., Takiguchi M., Greenwood B.M., Townsend A.R., et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992, 360:434-439.
14. Jobe O., Donofrio G., Sun G., Liepinsh D., Schwenk R., Krzych U. Immunization with radiation-attenuated Plasmodium berghei sporozoites induces liver cCD8alpha+DC that activate CD8+ T cells against liver-stage malaria. PLoS One 2009, 4:e5075.
15. Jobe O., Lumsden J., Mueller A.K., Williams J., Silva-Rivera H., Kappe S.H., Schwenk R.J., Matuschewski K., Krzych U. Genetically attenuated Plasmodium berghei liver stages induce sterile protracted protection that is mediated by major histocompatibility complex Class I-dependent interferon-gamma-producing CD8+ T cells. J. Infect. Dis. 2007, 196:599-607.
16. Kester K.E., Cummings J.F., Ofori-Anyinam O., Ockenhouse C.F., Krzych U., Moris P., Schwenk R., Nielsen R.A., Debebe Z., Pinelis E., Juompan L., Williams J., Dowler M., Stewart V.A., Wirtz R.A., Dubois M.C., Lievens M., Cohen J., Ballou W.R., Heppner D.G. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS, S/AS01B and RTS, S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 2009, 200:337-346.
17. Khusmith S., Charoenvit Y., Kumar S., Sedegah M., Beaudoin R.L., Hoffman S.L. Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science 1991, 252:715-718.
18. Kumar K.A., Sano G., Boscardin S., Nussenzweig R.S., Nussenzweig M.C., Zavala F., Nussenzweig V. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 2006, 444:937-940.
19. Lanar D.E., Tine J.A., de Taisne C., Seguin M.C., Cox W.I., Winslow J.P., Ware L.A., Kauffman E.B., Gordon D., Ballou W.R., Paoletti E., Sadoff J.C. Attenuated vaccinia virus-circumsporozoite protein recombinants confer protection against rodent malaria. Infect. Immun. 1996, 64:1666-1671.
20. Mellouk S., Green S.J., Nacy C.A., Hoffman S.L. IFN-gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an l-arginine-dependent effector mechanism. J. Immunol. 1991, 146:3971-3976.
21. Mellouk S., Hoffman S.L., Liu Z.Z., de la Vega P., Billiar T.R., Nussler A.K. Nitric oxide-mediated antiplasmodial activity in human and murine hepatocytes induced by gamma interferon and the parasite itself: enhancement by exogenous tetrahydrobiopterin. Infect. Immun. 1994, 62:4043-4046.
22. Moreno A., Clavijo P., Edelman R., Davis J., Sztein M., Herrington D., Nardin E. Cytotoxic CD4+ T cells from a sporozoite-immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol. 1991, 3:997-1003.
23. Muller H.M., Reckmann I., Hollingdale M.R., Bujard H., Robson K.J., Crisanti A. Thrombospondin related anonymous protein (TRAP) of Plasmodium falciparum binds specifically to sulfated glycoconjugates and to HepG2 hepatoma cells suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J. 1993, 12:2881-2889.
24. Nussenzweig R.S., Vanderberg J., Most H., Orton C. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. Nature 1967, 216:160-162.
25. Oliveira G.A., Kumar K.A., Calvo-Calle J.M., Othoro C., Altszuler D., Nussenzweig V., Nardin E.H. Class II-restricted protective immunity induced by malaria sporozoites. Infect. Immun. 2008, 76:1200-1206.
26. Potocnjak P., Yoshida N., Nussenzweig R.S., Nussenzweig V. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 1980, 151:1504-1513.
27. Reece W.H., Pinder M., Gothard P.K., Milligan P., Bojang K., Doherty T., Plebanski M., Akinwunmi P., Everaere S., Watkins K.R., Voss G., Tornieporth N., Alloueche A., Greenwood B.M., Kester K.E., McAdam K.P., Cohen J., Hill A.V. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat. Med. 2004, 10:406-410.
28. Renggli J., Hahne M., Matile H., Betschart B., Tschopp J., Corradin G. Elimination of P. berghei liver stages is independent of Fas (CD95/Apo-I) or perforin-mediated cytotoxicity. Parasite Immunol. 1997, 19:145-148.
29. Renia L., Grillot D., Marussig M., Corradin G., Miltgen F., Lambert P.H., Mazier D., Del Giudice G. Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol. 1993, 150:1471-1478.
30. Renia L., Rodrigues M.M., Nussenzweig V. Intrasplenic immunization with infected hepatocytes: a mouse model for studying protective immunity against malaria pre-erythrocytic stage. Immunology 1994, 82:164-168.
31. Rodrigues E.G., Claassen J., Lee S., Wilson J.M., Nussenzweig R.S., Tsuji M. Interferon-gamma-independent CD8+ T cell-mediated protective anti-malaria immunity elicited by recombinant adenovirus. Parasite Immunol. 2000, 22:157-160.
32. Rodrigues E.G., Zavala F., Eichinger D., Wilson J.M., Tsuji M. Single immunizing dose of recombinant adenovirus efficiently induces CD8+ T cell-mediated protective immunity against malaria. J. Immunol. 1997, 158:1268-1274.
33. Rodrigues M., Nussenzweig R.S., Romero P., Zavala F. The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med. 1992, 175:895-905.
34. Rodrigues M., Nussenzweig R.S., Zavala F. The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria. Immunology 1993, 80:1-5.
35. Rodrigues M.M., Cordey A.S., Arreaza G., Corradin G., Romero P., Maryanski J.L., Nussenzweig R.S., Zavala F. CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol. 1991, 3:579-585.
36. Rogers W.O., Malik A., Mellouk S., Nakamura K., Rogers M.D., Szarfman A., Gordon D.M., Nussler A.K., Aikawa M., Hoffman S.L. Characterization of Plasmodium falciparum sporozoite surface protein 2. Proc. Natl. Acad. Sci. USA 1992, 89:9176-9180.
37. Rogers W.O., Rogers M.D., Hedstrom R.C., Hoffman S.L. Characterization of the gene encoding sporozoite surface protein 2, a protective Plasmodium yoelii sporozoite antigen. Mol. Biochem. Parasitol. 1992, 53:45-51.
38. Romero P., Maryanski J.L., Corradin G., Nussenzweig R.S., Nussenzweig V., Zavala F. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 1989, 341:323-326.
39. Sadoff J.C., Ballou W.R., Baron L.S., Majarian W.R., Brey R.N., Hockmeyer W.T., Young J.F., Cryz S.J., Ou J., Lowell G.H., et al. Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science 1988, 240:336-338.
40. Sano G., Hafalla J.C., Morrot A., Abe R., Lafaille J.J., Zavala F. Swift development of protective effector functions in naive CD8(+) T cells against malaria liver stages. J. Exp. Med. 2001, 194:173-180.
41. Schmidt N.W., Butler N.S., Harty J.T. CD8 T cell immunity to Plasmodium permits generation of protective antibodies after repeated sporozoite challenge. Vaccine 2009, 27:6103-6106.
42. Schmidt N.W., Podyminogin R.L., Butler N.S., Badovinac V.P., Tucker B.J., Bahjat K.S., Lauer P., Reyes-Sandoval A., Hutchings C.L., Moore A.C., Gilbert S.C., Hill A.V., Bartholomay L.C., Harty J.T. Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc. Natl. Acad. Sci. USA 2008, 105:14017-14022.
43. Schofield L., Villaquiran J., Ferreira A., Schellekens H., Nussenzweig R., Nussenzweig V. Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature 1987, 330:664-666.
44. Schwenk R., Asher L.V., Chalom I., Lanar D., Sun P., White K., Keil D., Kester K.E., Stoute J., Heppner D.G., Krzych U. Opsonization by antigen-specific antibodies as a mechanism of protective immunity induced by Plasmodium falciparum circumsporozoite protein-based vaccine. Parasite Immunol. 2003, 25:17-25.
45. Seguin M.C., Klotz F.W., Schneider I., Weir J.P., Goodbary M., Slayter M., Raney J.J., Aniagolu J.U., Green S.J. Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: involvement of interferon gamma and CD8+ T cells. J. Exp. Med. 1994, 180:353-358.
46. Takita-Sonoda Y., Tsuji M., Kamboj K., Nussenzweig R.S., Clavijo P., Zavala F. Plasmodium yoelii: peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp Parasitol. 1996, 84:223-230.
47. Tsuji M., Miyahira Y., Nussenzweig R.S., Aguet M., Reichel M., Zavala F. Development of antimalaria immunity in mice lacking IFN-gamma receptor. J. Immunol. 1995, 154:5338-5344.
48. Tsuji M., Romero P., Nussenzweig R.S., Zavala F. CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 1990, 172:1353-1357.
49. Wang R., Charoenvit Y., Corradin G., De La Vega P., Franke E.D., Hoffman S.L. Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-gamma-dependent elimination of infected hepatocytes. J. Immunol. 1996, 157:4061-4067.
50. Weiss W.R., Mellouk S., Houghten R.A., Sedegah M., Kumar S., Good M.F., Berzofsky J.A., Miller L.H., Hoffman S.L. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 1990, 171:763-773.
51. Weiss W.R., Sedegah M., Beaudoin R.L., Miller L.H., Good M.F. CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 1988, 85:573-576.
52. Weiss W.R., Sedegah M., Berzofsky J.A., Hoffman S.L. The role of CD4+ T cells in immunity to malaria sporozoites. J. Immunol. 1993, 151:2690-2698.
53. White K.L., Snyder H.L., Krzych U. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J. Immunol. 1996, 156:3374-3381.
54. Yoshida N., Nussenzweig R.S., Potocnjak P., Nussenzweig V., Aikawa M. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science 1980, 207:71-73.